Cost-effectiveness of preimplantation genetic screening for women older than 37 undergoing in vitro fertilization
- 695 Downloads
Adding preimplantation genetic screening to in vitro fertilization has been shown to increase live birth rate in women older than 37. However, preimplantation genetic screening is an expensive procedure. Information on the cost-effectiveness of preimplantation genetic screening can help inform clinical decision making.
We constructed a decision analytic model for a hypothetical fresh, autologous in vitro fertilization cycle (with versus without preimplantation genetic screening) for women older than age 37 who had a successful oocyte retrieval and development of at least one blastocyst. The model incorporated probability and cost estimates of relevant clinical events based on data from published literature. Sensitivity analyses were performed to examine the impact of changes in model input parameters.
In base-case analysis, IVF-PGS offered a 4.2 percentage point increase in live birth rate for an additional cost of $4509, yielding an incremental cost-effectiveness ratio (ICER) of $105,489 per additional live birth. This ICER was below the expected cost of $145,063 for achieving one live birth with IVF (assuming an average LBR of 13.4% and $19,415 per cycle for this patient population). Sensitivity analysis suggested that ICER improved substantially with decreases in PGS cost and increases in PGS effectiveness. Monte Carlo simulation showed PGS to be cost-effective in 93.9% of iterations at an acceptability cutoff of $145,063.
Considering the expected cost of achieving one live birth with IVF, PGS is a cost-effective strategy for women older than 37 undergoing IVF. Additional research on patients’ willingness-to-pay per live birth would further inform our understanding regarding the cost-effectiveness of PGS.
KeywordsCost-effectiveness Preimplantation genetic screening In vitro fertilization Willingness-to-pay
We thank Ms. Jeani Chang (CDC) and Dr. Vanessa Dalton for kindly sharing unpublished data from their manuscripts for inclusion in our analysis.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
- 1.Centers for Disease Control and Prevention ASfRM, Society for Assisted Reproductive Technology, 2014 Assisted Reproductive Technology National Summary Report. In: US Dept of Health and Human Services, editor. Atlanta (GA)2016.Google Scholar
- 2.Mathews T, Hamilton BE. Mean age of mothers is on the rise: United States, 2000-2014. NCHS data brief. 2016(232):1–8.Google Scholar
- 9.Coates A, Kung A, Mounts E, Hesla J, Bankowski B, Barbieri E, et al. Optimal euploid embryo transfer strategy, fresh versus frozen, after preimplantation genetic screening with next generation sequencing: a randomized controlled trial. Fertil Steril 2017;107(3):723–730 e3.Google Scholar
- 12.Forman EJ, Upham KM, Cheng M, Zhao T, Hong KH, Treff NR, et al. Comprehensive chromosome screening alters traditional morphology-based embryo selection: a prospective study of 100 consecutive cycles of planned fresh euploid blastocyst transfer. Fertil Steril. 2013;100(3):718–24.CrossRefPubMedGoogle Scholar
- 13.Kang H-J, Melnick AP, Stewart JD, Xu K, Rosenwaks Z. Preimplantation genetic screening: who benefits? Fertil Steril. 2016;Google Scholar
- 21.Statistics BoL. Consumer Price Index: Bureau of Labor Statistics; [March 24, 2017]. Available from: http://www.bls.gov/cpi/.
- 28.Gleicher N, Vidali A, Braverman J, Kushnir VA, Barad DH, Hudson C, et al. Accuracy of preimplantation genetic screening (PGS) is compromised by degree of mosaicism of human embryos. Reprod Biol Endocrinol. 2016;14Google Scholar
- 32.Ubaldi FM, Capalbo A, Colamaria S, Ferrero S, Maggiulli R, Vajta G, et al. Reduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention study. Hum Reprod. 2015;30(9):2097–106.CrossRefPubMedPubMedCentralGoogle Scholar
- 35.Provost MP, Acharya KS, Acharya CR, Yeh JS, Steward RG, Eaton JL, et al. Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008-2010 Society for Assisted Reproductive Technology registry. Fertil Steril. 2016;105(3):663–9.CrossRefPubMedGoogle Scholar